{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:16:25Z","timestamp":1785428185387,"version":"3.56.0"},"reference-count":35,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015083","name":"Peking University People\u2019s Hospital","doi-asserted-by":"publisher","award":["2024-Z-114"],"award-info":[{"award-number":["2024-Z-114"]}],"id":[{"id":"10.13039\/501100015083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015083","name":"Peking University People\u2019s Hospital","doi-asserted-by":"publisher","award":["2026-Z-33"],"award-info":[{"award-number":["2026-Z-33"]}],"id":[{"id":"10.13039\/501100015083","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2024-Z-114"],"award-info":[{"award-number":["2024-Z-114"]}],"id":[{"id":"https:\/\/ror.org\/035adwg89","id-type":"ROR","asserted-by":"publisher"}]},{"award":["2026-Z-33"],"award-info":[{"award-number":["2026-Z-33"]}],"id":[{"id":"https:\/\/ror.org\/035adwg89","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objective: Dysthyroid Optic Neuropathy (DON) is a severe complication of Thyroid Eye Disease (TED) leading to irreversible visual impairment. Its pathogenesis remains unclear, and early predictive tools are lacking. The study aims to investigate peripheral immune characteristics associated with DON, focusing on the IL-2+Th1\/CD4+Tregs axis. Methods: A retrospective study was conducted in 37 TED patients, including DON (n = 22) and non-DON (n = 15) groups. Peripheral blood immune cell subsets were quantified using flow cytometry. Clinical data and peripheral blood immune indicators including T cell subsets, B cell subsets, T helper (Th) cell subsets, and regulatory T (Treg) cells populations were analyzed. Correlation and logistic regression analyses were applied to evaluate associations between immune indicators and DON. Receiver operating characteristic (ROC) analysis was used to assess the discriminatory performance of candidate variables and exploratory combined models. Results: Patients with DON showed higher IL-2+Th1 levels and lower CD4+Tregs levels compared with non-DON patients, along with an increased IL-2+Th1\/CD4+Tregs ratio. Age and clinical activity score also differed significantly between groups. The IL-2+Th1\/CD4+Tregs axis showed significant alterations associated with DON. The exploratory logistic regression model combining immune and clinical indicators showed potential discriminatory ability in differentiating DON from non-DON patients. Conclusions: This study identifies an imbalance between IL-2+Th1 and CD4+Tregs as a potential immune signature associated with DON. Integration of immune and clinical features may provide an exploratory framework for risk stratification in TED. Further prospective studies with larger cohorts are warranted to validate these findings.<\/jats:p>","DOI":"10.3390\/jcm15135283","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:56:42Z","timestamp":1783349802000},"page":"5283","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Peripheral IL-2+Th1\/CD4+Tregs Axis Imbalance and Dysthyroid Optic Neuropathy in Thyroid Eye Disease"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1240-2510","authenticated-orcid":false,"given":"Zelu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Piao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvzhen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing 100044, China"},{"name":"Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wang, L., and Chen, L. (2025). Emerging therapeutic approaches in graves\u2019 ophthalmopathy: An update on pharmacological interventions. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1647602"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2528046","DOI":"10.1155\/2022\/2528046","article-title":"Cytokines in Thyroid-Associated Ophthalmopathy","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_3","first-page":"72","article-title":"Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets","volume":"13","author":"Niedziela","year":"2024","journal-title":"J. Clin. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40618-020-01361-y","article-title":"Dysthyroid optic neuropathy: Evaluation and management","volume":"44","author":"Dolman","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/thy.2022.0251","article-title":"Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ma, Q., Hai, Y., Duan, Y., Yu, G., Song, C., Huang, S., Huang, A., Zhu, Y., Shen, Y., and Huang, Z. (2025). Inflammatory profiling and immune cell infiltration in dysthyroid optic neuropathy: Insights from bulk RNA sequencing. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1550694"},{"key":"ref_8","first-page":"166","article-title":"Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy","volume":"67","author":"Rutkowska","year":"2016","journal-title":"Endokrynol. Pol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40662-021-00238-2","article-title":"Modified endoscopic transnasal orbital apex decompression in dysthyroid optic neuropathy","volume":"8","author":"Tu","year":"2021","journal-title":"Eye Vis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101729","DOI":"10.1016\/j.ando.2025.101729","article-title":"Correlation between orbital immune cell subsets and clinical activity in thyroid eye disease","volume":"86","author":"Zhang","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Scarabosio, A., Surico, P.L., Singh, R.B., Tereshenko, V., Musa, M., D\u2019Esposito, F., Russo, A., Longo, A., Gagliano, C., and Agosti, E. (2024). Thyroid Eye Disease: Advancements in Orbital and Ocular Pathology Management. J. Pers. Med., 14.","DOI":"10.3390\/jpm14070776"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/thy.2024.0629","article-title":"Factors Associated with Response to Intravenous Glucocorticoids in Active Moderate-to-Severe Thyroid Eye Disease","volume":"35","author":"Baczewska","year":"2025","journal-title":"Thyroid"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s40618-023-02036-0","article-title":"Dysthyroid optic neuropathy: Emerging treatment strategies","volume":"46","year":"2023","journal-title":"J. Endocrinol. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/clinem\/dgad211","article-title":"Outcomes of Patients with Dysthyroid Optic Neuropathy Treated with Intravenous Corticosteroids and\/or Orbital Decompression Surgery: A Systematic Review and Meta-analysis","volume":"108","author":"Wang","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S2213-8587(25)00066-X","article-title":"Thyroid eye disease (Graves\u2019 orbitopathy): Clinical presentation, epidemiology, pathogenesis, and management","volume":"13","author":"Wiersinga","year":"2025","journal-title":"Lancet. Diabetes Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","article-title":"Diagnostic Criteria for Graves\u2019 Ophthalmopathy","volume":"119","author":"Bartley","year":"1995","journal-title":"AM. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-017-0002-5","article-title":"Targeting IL-2: An unexpected effect in treating immunological diseases","volume":"3","author":"Ye","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-med-073118-011031","article-title":"Engineering IL-2 to Give New Life to T Cell Immunotherapy","volume":"72","author":"Overwijk","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.intimp.2019.03.064","article-title":"New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases","volume":"72","author":"Xu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"DeOca, K.B., Moorman, C.D., Garcia, B.L., and Mannie, M.D. (2020). Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3(+) Tregs in vitro. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.541619"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/bloodadvances.2018027474","article-title":"Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease","volume":"3","author":"Whangbo","year":"2019","journal-title":"Blood Adv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103172","DOI":"10.1016\/j.jaut.2024.103172","article-title":"The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial","volume":"144","author":"Lorenzon","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-immunol-083122-044829","article-title":"B Cell-Directed Therapy in Autoimmunity","volume":"42","author":"Abeles","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e20200030","DOI":"10.1084\/jem.20200030","article-title":"TGF-\u03b2 and Eomes control the homeostasis of CD8+ regulatory T cells","volume":"218","author":"Mishra","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","article-title":"The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy","volume":"33","author":"Huang","year":"2019","journal-title":"Eye"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e181488","DOI":"10.1172\/jci.insight.181488","article-title":"Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves\u2019 ophthalmopathy","volume":"9","author":"Liu","year":"2024","journal-title":"JCI Insight"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12020-015-0662-2","article-title":"Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders","volume":"51","author":"Marazuela","year":"2016","journal-title":"Endocrine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wang, X., Ye, H., Chen, R., Yang, S., Zhang, T., Xiao, W., and Yang, H. (2023). HbA1c: An independent risk factor for dysthyroid optic neuropathy. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1251209"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ando.2023.04.002","article-title":"Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients","volume":"84","author":"Raymond","year":"2023","journal-title":"Ann. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yuan, X., Li, H., and Wang, F. (2026). The therapeutic revolution in thyroid eye disease: From orbital radiotherapy to teprotumumab and AI. Front. Med., 13.","DOI":"10.3389\/fmed.2026.1758015"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/s41467-025-62628-7","article-title":"Regulatory T cell therapy promotes TGF-\u03b2 and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101231","DOI":"10.1016\/j.arr.2020.101231","article-title":"Thymus involution sets the clock of the aging T-cell landscape: Implications for declined immunity and tissue repair","volume":"65","author":"Elyahu","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ma, C., Li, H., Lu, S., and Li, X. (2024). Thyroid-associated ophthalmopathy and ferroptosis: A review of pathological mechanisms and therapeutic strategies. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1475923"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"109235","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5283\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:30:40Z","timestamp":1783351840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":35,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15135283"],"URL":"https:\/\/doi.org\/10.3390\/jcm15135283","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]}}}